- Home
- RZLT vs REAL Comparison
RZLT vs REAL Comparison
Compare RZLT & REAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RZLT
- REAL
- Stock Information
- Founded
- RZLT 2010
- REAL 2011
- Country
- RZLT United States
- REAL United States
- Employees
- RZLT N/A
- REAL N/A
- Industry
- RZLT Biotechnology: Pharmaceutical Preparations
- REAL Other Specialty Stores
- Sector
- RZLT Health Care
- REAL Consumer Discretionary
- Exchange
- RZLT Nasdaq
- REAL Nasdaq
- Market Cap
- RZLT 292.0M
- REAL 982.8M
- IPO Year
- RZLT N/A
- REAL 2019
- Fundamental
- Price
- RZLT $4.59
- REAL $10.02
- Analyst Decision
- RZLT Strong Buy
- REAL Buy
- Analyst Count
- RZLT 8
- REAL 6
- Target Price
- RZLT $11.63
- REAL $7.04
- AVG Volume (30 Days)
- RZLT 373.9K
- REAL 3.8M
- Earning Date
- RZLT 02-11-2025
- REAL 11-04-2024
- Dividend Yield
- RZLT N/A
- REAL N/A
- EPS Growth
- RZLT N/A
- REAL N/A
- EPS
- RZLT N/A
- REAL N/A
- Revenue
- RZLT N/A
- REAL $579,862,000.00
- Revenue This Year
- RZLT N/A
- REAL $11.26
- Revenue Next Year
- RZLT N/A
- REAL $8.81
- P/E Ratio
- RZLT N/A
- REAL N/A
- Revenue Growth
- RZLT N/A
- REAL 2.52
- 52 Week Low
- RZLT $0.88
- REAL $1.52
- 52 Week High
- RZLT $6.19
- REAL $9.78
- Technical
- Relative Strength Index (RSI)
- RZLT 44.97
- REAL 73.33
- Support Level
- RZLT $4.07
- REAL $9.00
- Resistance Level
- RZLT $4.68
- REAL $9.73
- Average True Range (ATR)
- RZLT 0.33
- REAL 0.73
- MACD
- RZLT -0.01
- REAL -0.03
- Stochastic Oscillator
- RZLT 37.50
- REAL 88.06
About RZLT Rezolute Inc. (NV)
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.
About REAL The RealReal Inc.
The RealReal is the largest pure-play luxury resale platform in the us, generating $1.7 billion in 2023 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 34% of net merchandise value, which excludes returns, cancellations, and first-party sales.